Literature DB >> 25964048

Stealth Nanogels of Histinylated Poly Ethyleneimine for Sustained Delivery of Methotrexate in Collagen-Induced Arthritis Model.

SamiraSadat Abolmaali1, AliMohammad Tamaddon2, Eskandar Kamali-Sarvestani3, MohammadJavad Ashraf4, Rasoul Dinarvand5.   

Abstract

PURPOSE: The study aimed to illustrate application of polycation Stealth nanogels for sustained delivery of methotrexate (MTX) in collagen induced arthritis (CIA) model in C57Bl/6 mice.
METHODS: Nanogel synthesis involves metal ion coordinated self-assembly of PEGylated poly ethyleneimine (L-histidine substituted), chemical crosslinking and subsequent removal of the coordinated metal. The nanogels were characterized by TEM and DLS-zeta potential. Comparative efficacy and pharmacokinetics of the i.v. administred MTX-loaded nanogels were investigated in the CIA model. Inflammation site passive accumulation of the fluorophore-labeled nanogels was tested using in-vivo imaging of mice paw received unilateral injection of lipopolysaccharide.
RESULTS: Uniform nanogels (sizes ~40 nm by TEM) were loaded with MTX (entrapment efficiency = 62% and drug loading = 54% at the MTX feeding ratio of 0.3 relative to total molar concentration of the polymer amines). The nanogels exhibited neutral surface charge and an acceptable biocompatibility in terms of albumin aggregation, hemolysis, erythrocyte aggregation and cytotoxicity. Single dose pharmacokinetics of the MTX-loaded nanogels, unlike free drug, showed a sustained plasma profile. When arthritis established as confirmed by histopathology, a remarkable decline of paw swelling and clinical scores was observed. Fluorescence intensity of the nanogels was enhanced about 2.7 folds at the inflamed than control normal ankle.
CONCLUSION: Sustained delivery of MTX and preferential accumulation of the nanogels in inflamed paw might explain the superior clinical outcome of the MTX-loaded nanogels.

Entities:  

Keywords:  clinical efficacy; collagen induced arthritis; methotrexate; pharmacokinetics; stealth nanogels

Mesh:

Substances:

Year:  2015        PMID: 25964048     DOI: 10.1007/s11095-015-1708-0

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  42 in total

Review 1.  Benefit and risk of methotrexate treatment in rheumatoid arthritis.

Authors:  R Rau; G Herborn
Journal:  Clin Exp Rheumatol       Date:  2004 Sep-Oct       Impact factor: 4.473

2.  Stabilized nanocarriers for plasmids based upon cross-linked poly(ethylene imine).

Authors:  Michael Neu; Johannes Sitterberg; Udo Bakowsky; Thomas Kissel
Journal:  Biomacromolecules       Date:  2006-12       Impact factor: 6.988

3.  SYNTHESIS OF NANOGEL CARRIERS FOR DELIVERY OF ACTIVE PHOSPHORYLATED NUCLEOSIDE ANALOGUES.

Authors:  Serguei V Vinogradov; Alexander V Kabanov
Journal:  Polymer Prepr       Date:  2004-08-22

Review 4.  Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells.

Authors:  Serguei V Vinogradov; Tatiana K Bronich; Alexander V Kabanov
Journal:  Adv Drug Deliv Rev       Date:  2002-01-17       Impact factor: 15.470

5.  Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells.

Authors:  Nathan Kohler; Conroy Sun; Jassy Wang; Miqin Zhang
Journal:  Langmuir       Date:  2005-09-13       Impact factor: 3.882

6.  Albumin-based drug delivery as novel therapeutic approach for rheumatoid arthritis.

Authors:  Andreas Wunder; Ulf Müller-Ladner; Ernst H K Stelzer; Jürgen Funk; Elena Neumann; Gerd Stehle; Thomas Pap; Hannsjörg Sinn; Steffen Gay; Christoph Fiehn
Journal:  J Immunol       Date:  2003-05-01       Impact factor: 5.422

7.  Targeted drug delivery by in vivo coupling to endogenous albumin: an albumin-binding prodrug of methotrexate (MTX) is better than MTX in the treatment of murine collagen-induced arthritis.

Authors:  C Fiehn; F Kratz; G Sass; U Müller-Ladner; E Neumann
Journal:  Ann Rheum Dis       Date:  2008-04-13       Impact factor: 19.103

8.  The pharmacokinetics of methotrexate after intravenous administration of methotrexate-loaded proliposomes to rats.

Authors:  J M Park; B N Ahn; E J Yoon; M G Lee; C K Shim; C K Kim
Journal:  Biopharm Drug Dispos       Date:  1994-07       Impact factor: 1.627

9.  In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis.

Authors:  Dagmar Fischer; Youxin Li; Barbara Ahlemeyer; Josef Krieglstein; Thomas Kissel
Journal:  Biomaterials       Date:  2003-03       Impact factor: 12.479

Review 10.  Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis.

Authors:  Alisa E Koch; Oliver Distler
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

View more
  5 in total

1.  Core-Shell Imidazoline-Functionalized Mesoporous Silica Superparamagnetic Hybrid Nanoparticles as a Potential Theranostic Agent for Controlled Delivery of Platinum(II) Compound.

Authors:  Mehdi Abedi; Samira Sadat Abolmaali; Mozhgan Abedanzadeh; Fatemeh Farjadian; Soliman Mohammadi Samani; Ali Mohammad Tamaddon
Journal:  Int J Nanomedicine       Date:  2020-04-20

2.  Liposomal formulation of a methotrexate lipophilic prodrug: assessment in tumor cells and mouse T-cell leukemic lymphoma.

Authors:  Anna A Alekseeva; Ekaterina V Moiseeva; Natalia R Onishchenko; Ivan A Boldyrev; Alexander S Singin; Andrey P Budko; Zoya S Shprakh; Julian G Molotkovsky; Elena L Vodovozova
Journal:  Int J Nanomedicine       Date:  2017-05-15

3.  Effect of PEGylation on assembly morphology and cellular uptake of poly ethyleneimine-cholesterol conjugates for delivery of sorafenib tosylate in hepatocellular carcinoma.

Authors:  Maryam Monajati; Shirin Tavakoli; Samira Sadat Abolmaali; Gholamhossein Yousefi; AliMohammad Tamaddon
Journal:  Bioimpacts       Date:  2018-04-18

Review 4.  Intraocular Implants for the Treatment of Autoimmune Uveitis.

Authors:  Darren J Lee
Journal:  J Funct Biomater       Date:  2015-07-31

5.  Redox-sensitive, PEG-shielded carboxymethyl PEI nanogels silencing MicroRNA-21, sensitizes resistant ovarian cancer cells to cisplatin.

Authors:  Sanaz Javanmardi; Ali Mohammad Tamaddon; Mahmoud Reza Aghamaali; Ladan Ghahramani; Samira Sadat Abolmaali
Journal:  Asian J Pharm Sci       Date:  2018-12-01       Impact factor: 6.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.